We are live on
!
Find out more
AG
Aperio Group Portfolio holdings
AUM
$33.8B
1-Year Est. Return
31.46%
This Fund
S&P 500
This Quarter
Est. Return
+13.58%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
–
AUM
$23.2B
AUM Growth
+$3.33B
(+17%)
Cap. Flow
+$831M
Cap. Flow
% of AUM
3.59%
Top 10 Holdings %
Top 10 Hldgs %
15.41%
Holding
2,365
New
77
Increased
1,233
Reduced
966
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$36.9M |
| 2 |
Amazon
AMZN
|
+$32.4M |
| 3 |
PepsiCo
PEP
|
+$31.5M |
| 4 |
Meta Platforms (Facebook)
META
|
+$29.6M |
| 5 |
AT&T
T
|
+$26.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$38.7M |
| 2 |
CVS Health
CVS
|
+$25.9M |
| 3 |
SHPG
Shire pic
SHPG
|
+$24.1M |
| 4 |
Consolidated Edison
ED
|
+$20.1M |
| 5 |
Amdocs
DOX
|
+$19.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.4% |
| 2 | Financials | 15.96% |
| 3 | Healthcare | 13.51% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZGNX
2026
DELISTED
Zogenix, Inc.
ZGNX
| $282K | ﹤0.01% |
+5,113
| New | +$243K |
|
|
PGTI
2027
DELISTED
PGT, Inc.
PGTI
| $281K | ﹤0.01% |
20,309
-373
| -2% | -$5.9K |
|
2028
Ezcorp Inc
EZPW
$1.79B
| $280K | ﹤0.01% |
30,040
+5,151
| +21% | +$48.6K |
|
2029
Ironwood Pharmaceuticals
IRWD
$614M
| $280K | ﹤0.01% |
24,694
+2,865
| +13% | +$32K |
|
2030
Rambus
RMBS
$9.72B
| $280K | ﹤0.01% |
26,766
+961
| +4% | +$9.22K |
|
2031
Amneal Pharmaceuticals
AMRX
$5.91B
| $279K | ﹤0.01% |
19,663
-15,648
| -44% | -$207K |
|
2032
MacroGenics
MGNX
$240M
| $279K | ﹤0.01% |
+15,494
| New | +$268K |
|
|
IMMU
2033
DELISTED
Immunomedics Inc
IMMU
| $279K | ﹤0.01% |
14,532
+1,597
| +12% | +$25.7K |
|
2034
Ameris Bancorp
ABCB
$5.88B
| $278K | ﹤0.01% |
8,080
+1,548
| +24% | +$57.6K |
|
2035
Movado Group
MOV
$849M
| $278K | ﹤0.01% |
7,643
+145
| +2% | +$4.86K |
|
2036
TriNet
TNET
$3.29B
| $278K | ﹤0.01% |
+4,658
| New | +$246K |
|
|
AKRX
2037
DELISTED
Akorn Inc
AKRX
| $278K | ﹤0.01% |
78,906
+5,019
| +7% | +$19.3K |
|
|
DBD
2038
DELISTED
Diebold Nixdorf Incorporated
DBD
| $277K | ﹤0.01% |
25,041
+8,531
| +52% | +$59.6K |
|
|
WW
2039
DELISTED
WW International
WW
| $276K | ﹤0.01% |
13,710
+1,365
| +11% | +$37.7K |
|
|
ISBC
2040
DELISTED
Investors Bancorp, Inc.
ISBC
| $276K | ﹤0.01% |
23,263
-2,827
| -11% | -$34.1K |
|
|
ARCH
2041
DELISTED
Arch Resources, Inc.
ARCH
| $276K | ﹤0.01% |
+3,023
| New | +$266K |
|
|
SHOE
2042
Shoe Station Group
SHOE
$420M
| $275K | ﹤0.01% |
16,138
-2,252
| -12% | -$40.9K |
|
2043
Churchill Downs
CHDN
$5.76B
| $274K | ﹤0.01% |
6,068
-11,014
| -64% | -$492K |
|
2044
Generac Holdings
GNRC
$11.3B
| $274K | ﹤0.01% |
5,355
+1,220
| +30% | +$63.7K |
|
2045
Insmed
INSM
$22B
| $274K | ﹤0.01% |
+9,425
| New | +$244K |
|
2046
Kinsale Capital Group
KNSL
$8.11B
| $274K | ﹤0.01% |
+4,002
| New | +$250K |
|
2047
Newmark Group
NMRK
$2.68B
| $274K | ﹤0.01% |
32,885
-11,707
| -26% | -$111K |
|
2048
Theravance Biopharma
TBPH
$873M
| $274K | ﹤0.01% |
12,064
+3,652
| +43% | +$92.6K |
|
2049
Warrior Met Coal
HCC
$4.25B
| $273K | ﹤0.01% |
8,977
-1,029
| -10% | -$28.2K |
|
2050
Travere Therapeutics
TVTX
$5.33B
| $271K | ﹤0.01% |
11,976
+2,810
| +31% | +$62.1K |
|
Similar funds
OU
CTA
GAM
CCI
SWM
LCM
HCMNY
BII
Aperio Group's Q1 2019 Portfolio in Review
As of Q1 2019, Aperio Group held 2,365 positions worth $23.2B, up 17% from $19.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Aperio Group deployed $831M of net new capital in Q1 2019, opening 77 new positions and adding to 1,233 existing holdings. Its largest new stake was Fox Class A: 279,082 shares worth $10.2M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was CVS Health, an estimated $25.9M trimmed.
- Aperio Group's largest Q1 2019 buy was Fox Class A: 279,082 shares worth $10.2M.
- Aperio Group added most to Walt Disney in Q1 2019, an estimated $36.9M increase.
- Aperio Group's biggest Q1 2019 reduction was CVS Health, cutting an estimated $25.9M.
- Aperio Group fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $38.7M.
- Aperio Group's ten largest holdings make up 15% of its $23.2B portfolio in Q1 2019.
- Aperio Group opened 77 new positions and closed 81 in Q1 2019.
- Aperio Group's portfolio value rose 17% quarter-over-quarter to $23.2B.
Based on Aperio Group's 13F filing for Q1 2019, filed 13 May 2019.